Cargando…
Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma
BACKGROUND: Adrenocortical carcinoma (ACC) is an aggressive and rare neoplasm that originates from the cortex of the adrenal gland. N6-methyladenosine (m6A) RNA methylation, the most common form of mRNA modification, has been reported to be correlated with the occurrence and development of the malig...
Autores principales: | Shen, Chengquan, Liu, Jing, Yang, Xiaokun, Jiao, Wei, Wang, Yonghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937949/ https://www.ncbi.nlm.nih.gov/pubmed/33692753 http://dx.doi.org/10.3389/fendo.2021.568397 |
Ejemplares similares
-
Prognostic Alternative mRNA Splicing in Adrenocortical Carcinoma
por: Liang, Weiwei, et al.
Publicado: (2021) -
Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment
por: Libé, Rossella
Publicado: (2015) -
Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma
por: Xu, Fangshi, et al.
Publicado: (2021) -
Identification of Seven Aberrantly Methylated and Expressed Genes in Adrenocortical Carcinoma
por: Xiao, He, et al.
Publicado: (2019) -
Pediatric adrenocortical carcinoma
por: Ilanchezhian, Maran, et al.
Publicado: (2022)